Mangoceuticals, Inc. (MGRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Mangoceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -0.36x | -0.55x | -0.48x | -34.66x | -3381.73x |
| P/B Ratio | 0.49x | 0.34x | 5.75x | 112.80x | -3580.14x |
| P/S Ratio | 16.34x | 7.78x | 6.09x | 7748.07x | 0.00x |
| Profitability | |||||
| Gross Margin | 54.9% | 61.7% | 59.0% | 54.3% | 0.0% |
| Operating Margin | -4200.5% | -1294.4% | -1260.3% | -22279.7% | 0.0% |
| Net Margin | -4526.9% | -1413.6% | -1259.4% | -22352.1% | 0.0% |
| EBITDA Margin | -4126.1% | -1292.8% | -1106.4% | -22236.5% | 0.0% |
| Liquidity | |||||
| Current Ratio | 1.74x | 0.05x | 3.88x | 2.67x | 0.57x |
| Quick Ratio | 1.74x | 0.05x | 3.79x | 2.67x | 0.57x |
| Leverage | |||||
| Debt/Equity | 0.02x | 0.02x | 0.17x | 0.57x | -2.35x |
YoY = year-over-year change. Source: FMP..